Aldeyra Therapeutics, Inc.
(NASDAQ : ALDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.35%183.621.1%$863.15m
GILDGilead Sciences, Inc.
-0.31%80.690.9%$827.70m
CELGCelgene Corporation
0.98%94.771.2%$768.34m
JUNOJuno Therapeutics, Inc.
1.96%86.6513.5%$580.24m
BIIBBiogen Inc.
0.50%288.901.2%$512.51m
REGNRegeneron Pharmaceuticals, Inc.
-1.09%319.532.7%$396.39m
VRTXVertex Pharmaceuticals Incorporated
-1.63%158.361.9%$353.51m
ALXNAlexion Pharmaceuticals, Inc.
-0.50%118.262.0%$255.34m
NKTRNektar Therapeutics
1.35%84.586.0%$250.40m
ILMNIllumina, Inc.
0.01%226.583.5%$230.72m
BLUEBluebird Bio, Inc.
2.19%209.9516.1%$196.16m
AAgilent Technologies, Inc.
1.41%72.081.5%$178.08m
INCYIncyte Corporation
0.48%85.922.5%$154.85m
BMRNBioMarin Pharmaceutical Inc.
1.09%84.764.4%$122.49m
EXASExact Sciences Corporation
-0.32%47.8626.0%$117.80m

Company Profile

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.